drugset / Trial / NCT02038569

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

NCT02038569

Phase 2 Completed 125 enrolled LEO Pharma
NaSingle-groupOpen-labelTreatment

Summary

An international, multi-centre, prospective, non-controlled, open, single-group, 8-week trial in adolescent subjects (aged 12 to 16 years, 11 months) with scalp and body psoriasis.

Timeline

Start
2014-01
Primary completion
2018-02
Completion
2018-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 0.5 mg
Subject Calcipotriol Small molecule 50 ug

Indications